Incyte (INCY) Treasury Shares (2013 - 2019)
Incyte's (INCY) quarterly Treasury Shares came in at $66666.0 in Q2 2019, down 93.61% YoY from $1.0 million in Q2 2018, and down 83.38% on a QoQ basis from $401040.0 in Q1 2019.
Incyte (INCY) Treasury Shares (2013 - 2019) Analysis & Trends
Incyte (INCY) has 7 years of Treasury Shares data on file, last reported at $66666.0 in Q2 2019.
- Quarterly Treasury Shares fell 93.61% year-over-year to $66666.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $66666.0 (down 93.61% YoY) and the FY2018 annual result came in at $545751.0, down 29.05% from the prior year.
- Treasury Shares slipped to $66666.0 in Q2 2019, from $401040.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.5 million in Q2 2016 to a low of $66666.0 in Q2 2019.
- A 5-year average of $821705.3 and a median of $832846.0 in 2015 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2016 — Treasury Shares jumped 81.89% — and 2019, when it sank 93.61%.
- Tracing INCY's Treasury Shares over 5 years: stood at $834433.0 in 2015, then soared by 37.36% to $1.1 million in 2016, then sank by 32.89% to $769202.0 in 2017, then fell by 29.05% to $545751.0 in 2018, then tumbled by 87.78% to $66666.0 in 2019.
- The last three Treasury Shares figures came in at $66666.0 (Q2 2019), $401040.0 (Q1 2019), and $545751.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 66,666.00 |
| Jun 30, 2019 | 66,666.00 |
| Mar 31, 2019 | 401,040.00 |
| Mar 31, 2019 | 401,040.00 |
| Dec 31, 2018 | 545,751.00 |
| Dec 31, 2018 | 545,751.00 |
| Sep 30, 2018 | 472,995.00 |
| Sep 30, 2018 | 472,995.00 |
| Jun 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 704,894.00 |
| Mar 31, 2018 | 704,894.00 |
| Dec 31, 2017 | 769,202.00 |
| Dec 31, 2017 | 769,202.00 |
| Sep 30, 2017 | 791,197.00 |
| Sep 30, 2017 | 791,197.00 |
| Jun 30, 2017 | 1.08 Mn |
| Jun 30, 2017 | 1.08 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Mar 31, 2017 | 1.09 Mn |